Kishimoto Koji, Liu Shumei, Tsuji Takanori, Olson Karen A, Hu Guo-Fu
Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 930, Boston, MA 02115, USA.
Oncogene. 2005 Jan 13;24(3):445-56. doi: 10.1038/sj.onc.1208223.
Angiogenin is an angiogenic protein that undergoes nuclear translocation in endothelial cells where it accumulates in the nucleolus and stimulates rRNA transcription, a rate-limiting step in ribosome biogenesis, protein translation, and cell growth. Here, we report that angiogenin is required for cell proliferation induced by various other angiogenic proteins including acidic and basic fibroblast growth factors (aFGF and bFGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF). Downregulation of angiogenin in endothelial cells by small interfering RNA (siRNA) and antisense results in a decrease in rRNA transcription, ribosome biogenesis, and cell proliferation induced by these angiogenic factors. Inhibitors of the nuclear translocation of angiogenin abolish the angiogenic activities of these factors. Stable angiogenin antisense transfection in HeLa cells reduces tumor angiogenesis in athymic mice despite the elevated expression level of bFGF and VEGF. Thus, nuclear angiogenin assumes an essential role in endothelial cell proliferation and is necessary for angiogenesis induced by other angiogenic factors. Angiogenin-stimulated rRNA transcription in endothelial cells may thus serve as a crossroad in the process of angiogenesis induced by various angiogenic factors.
血管生成素是一种促血管生成蛋白,在内皮细胞中发生核转位,在核仁中积累并刺激核糖体生物合成、蛋白质翻译和细胞生长中的限速步骤——rRNA转录。在此,我们报告血管生成素是包括酸性和碱性成纤维细胞生长因子(aFGF和bFGF)、表皮生长因子(EGF)和血管内皮生长因子(VEGF)在内的多种其他促血管生成蛋白诱导细胞增殖所必需的。通过小干扰RNA(siRNA)和反义核酸下调内皮细胞中的血管生成素会导致rRNA转录、核糖体生物合成以及这些促血管生成因子诱导的细胞增殖减少。血管生成素核转位抑制剂会消除这些因子的促血管生成活性。在HeLa细胞中稳定转染血管生成素反义核酸可减少无胸腺小鼠的肿瘤血管生成,尽管bFGF和VEGF的表达水平有所升高。因此,核血管生成素在内皮细胞增殖中起关键作用,并且是其他促血管生成因子诱导血管生成所必需的。血管生成素刺激内皮细胞中的rRNA转录可能因此在各种促血管生成因子诱导的血管生成过程中起到交叉点的作用。